Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine
· Delayed Price · Currency is JOD 3.620
+0.020 (0.56%)
At close: Jan 13, 2026
PEX:BJP Cash Flow Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 2.73 | 1.76 | 1.84 | 1.98 | 0.87 | Upgrade
|
| Depreciation & Amortization | 2.97 | 0.68 | 1.1 | 0.95 | 1.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.06 | Upgrade
|
| Other Operating Activities | 0.38 | 0.01 | -0.08 | 0.44 | 0.47 | Upgrade
|
| Change in Accounts Receivable | -1.47 | -1.39 | 0.98 | -0.32 | -1.13 | Upgrade
|
| Change in Inventory | -0.6 | -0.25 | -0.32 | 0.16 | -0.88 | Upgrade
|
| Change in Accounts Payable | 0.29 | 0.09 | -0.6 | 0 | -0.04 | Upgrade
|
| Change in Other Net Operating Assets | 0.17 | 0.01 | -0.98 | 0 | 0.73 | Upgrade
|
| Operating Cash Flow | 4.47 | 0.91 | 1.94 | 3.22 | 1.09 | Upgrade
|
| Operating Cash Flow Growth | 393.71% | -53.24% | -39.85% | 195.60% | -43.36% | Upgrade
|
| Capital Expenditures | -4.32 | -0.69 | -1.27 | -0.4 | -0.82 | Upgrade
|
| Investment in Securities | -0.38 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | - | 0.28 | 0.15 | 0.02 | Upgrade
|
| Investing Cash Flow | -4.7 | -0.69 | -0.99 | -0.26 | -0.8 | Upgrade
|
| Short-Term Debt Issued | - | 0.96 | - | - | 1.53 | Upgrade
|
| Total Debt Issued | - | 0.96 | - | - | 1.53 | Upgrade
|
| Short-Term Debt Repaid | -0.57 | - | -0.52 | -0.77 | - | Upgrade
|
| Long-Term Debt Repaid | -0.26 | -0.44 | -0.38 | -0.72 | -0.41 | Upgrade
|
| Total Debt Repaid | -0.83 | -0.44 | -0.9 | -1.49 | -0.41 | Upgrade
|
| Net Debt Issued (Repaid) | -0.83 | 0.52 | -0.9 | -1.49 | 1.12 | Upgrade
|
| Common Dividends Paid | -0.84 | -0.7 | -0.7 | -0.7 | -0.7 | Upgrade
|
| Financing Cash Flow | -1.67 | -0.18 | -1.6 | -2.19 | 0.42 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.37 | -0.18 | 0.26 | -0.53 | - | Upgrade
|
| Net Cash Flow | 0.47 | -0.14 | -0.39 | 0.24 | 0.71 | Upgrade
|
| Free Cash Flow | 0.15 | 0.22 | 0.67 | 2.81 | 0.27 | Upgrade
|
| Free Cash Flow Growth | -33.42% | -67.37% | -76.19% | 950.86% | - | Upgrade
|
| Free Cash Flow Margin | 1.14% | 2.26% | 6.97% | 26.14% | 2.75% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.03 | 0.10 | 0.40 | 0.04 | Upgrade
|
| Cash Income Tax Paid | - | 0.14 | 0.36 | 0.1 | 0.14 | Upgrade
|
| Levered Free Cash Flow | -0.9 | -0.44 | -0.04 | 2.07 | -0.46 | Upgrade
|
| Unlevered Free Cash Flow | -0.87 | -0.38 | 0.03 | 2.15 | -0.4 | Upgrade
|
| Change in Working Capital | -1.62 | -1.54 | -0.92 | -0.15 | -1.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.